- Home
- JOBY vs ASND Comparison
JOBY vs ASND Comparison
Compare JOBY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOBY | ASND |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | JOBY | ASND |
|---|---|---|
| Price | $14.73 | $209.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 15 |
| Target Price | $13.43 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 16.5M | 794.8K |
| Earning Date | 11-05-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $22,644,000.00 | ★ $758,592,045.00 |
| Revenue This Year | $25,259.56 | $99.74 |
| Revenue Next Year | $232.19 | $79.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1934.50 | 97.46 |
| 52 Week Low | $4.96 | $118.03 |
| 52 Week High | $20.95 | $229.94 |
Technical Indicators
Market Signals| Indicator | JOBY | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 52.35 |
| Support Level | $13.25 | $197.16 |
| Resistance Level | $15.98 | $213.22 |
| Average True Range (ATR) | 0.85 | 10.30 |
| MACD | -0.01 | -0.44 |
| Stochastic Oscillator | 54.21 | 45.54 |
Price Performance
Historical ComparisonAbout JOBY Joby Aviation Inc.
Joby Aviation Inc is a transportation company developing an all-electric, vertical take-off and landing (eVTOL) air taxi for commercial passenger service. Its Joby eVTOL aircraft is designed to transport a pilot and up to four passengers or an expected payload of up to 1,000 pounds at speeds of up to 200 mph. The aircraft is optimized for urban routes, with a target range of up to 100 miles on a single charge. The company is also developing an app-based platform to build and operate an aerial ridesharing service powered by a network of eVTOL aircraft that it will manufacture and operate. It has one operating and reportable segment, namely flight services. Currently, the company generates all of its revenue from flight services provided to the Department of Defense in the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.